TNFSF8 Polyclonal antibody

TNFSF8 Polyclonal Antibody for IHC, ELISA
Cat No. 17852-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

IHC, ELISA

CD153, CD30 L, CD30 ligand, CD30L, CD30LG, TNFSF8

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IHC detected inhuman liver cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17852-1-AP targets TNFSF8 in IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen TNFSF8 fusion protein Ag12303 Predict reactive species
Full Name tumor necrosis factor (ligand) superfamily, member 8
Calculated Molecular Weight 234 aa, 26 kDa
Observed Molecular Weight 35-40 kDa
GenBank Accession NumberBC093630
Gene Symbol TNFSF8
Gene ID (NCBI) 944
RRIDAB_2878452
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDP32971
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TNFSF8, also named as CD30LG and CD153, is a member of the tumor necrosis factor (TNF) receptor superfamily, is a surface antigen used as a clinical marker for Hodgkin lymphoma and related hematologic malignancies. It induces proliferation of T-cells. CD30L enhanced the proliferation of CD3-activated T cells, but induced differential responses, including cell death, in several CD30-positive lymphoma-derived cell lines. For Glycosylation, the MW in WB detection is about 35-40 kDa.

Protocols

Product Specific Protocols
WB protocol for TNFSF8 antibody 17852-1-APDownload protocol
IHC protocol for TNFSF8 antibody 17852-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...